CDRH Acting Director Jeffrey Shuren Vies For Permanent Spot
This article was originally published in The Gray Sheet
Executive Summary
Acting device center director Jeffrey Shuren is vying to head the center permanently. He announced his candidacy to agency staff last week, according to Principal Deputy FDA Commissioner Joshua Sharfstein
You may also be interested in...
CDRH Pre-Market Reform Proposals Expected Within Weeks
The FDA device center's upcoming proposals for reforming its pre-market policies will directly address widespread industry concern that reviews are increasingly unpredictable and opaque, CDRH Director Jeff Shuren told an industry audience last week
CDRH Pre-Market Reform Proposals Expected Within Weeks
The FDA device center's upcoming proposals for reforming its pre-market policies will directly address widespread industry concern that reviews are increasingly unpredictable and opaque, CDRH Director Jeff Shuren told an industry audience last week
Device Center Detractor Speaks Out At FDA Radiation Meeting
Managers in FDA's device center "ignored and suppressed" significant public health concerns about imaging systems in their past reviews of some such devices, according to a scientist who spoke at a recent FDA meeting